Clinical outcomes of MitraClip for the treatment of functional mitral regurgitation

EuroIntervention

Volumn 10, Issue 6, 2014, Pages 746-752

  Taramasso, Maurizio ^a   Maisano, Francesco ^a   Latib, Azeem ^a   Denti, Paolo ^a   Buzzatti, Nicola ^a   Cioni, Micaela ^a   La Canna, Giovanni ^a   Colombo, Antonio ^a   Alfieri, Ottavio ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

Biochemical markers; Edge to edge repair; Mitral valve disease; Valvular heart disease

Indexed keywords

ADRENALIN; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; INOTROPIC AGENT;

AGED; ANGIOCARDIOGRAPHY; ARTICLE; ASSISTED CIRCULATION; BLOOD VESSEL CLIP; CARDIOGENIC SHOCK; CARDIOVASCULAR MORTALITY; CHRONIC KIDNEY FAILURE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL EFFECTIVENESS; COMORBIDITY; CONGESTIVE CARDIOMYOPATHY; CONVERSION TO OPEN SURGERY; DIABETES MELLITUS; DISEASE SEVERITY; DOPPLER ECHOCARDIOGRAPHY; EMPHYSEMA; EUROSCORE; FEMALE; FOLLOW UP; FUNCTIONAL MITRAL VALVE REGURGITATION; HEART EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART MUSCLE ISCHEMIA; HEMATOTHORAX; HIGH RISK PATIENT; HOSPITAL DISCHARGE; HUMAN; IMPLANTABLE CLIP; INTENSIVE CARE UNIT; INTRAAORTIC BALLOON PUMP; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; MULTIPLE ORGAN FAILURE; NEW YORK HEART ASSOCIATION CLASS; OUTCOME ASSESSMENT; PATIENT SAFETY; PREOPERATIVE EVALUATION; PROGNOSIS; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTOR; SURVIVAL RATE; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; CARDIOVASCULAR RISK; CLINICAL FEATURE; CONTROLLED STUDY; EMPHYSEMATOUS BULLA RUPTURE; FUNCTIONAL MITRAL REGURGITATION; FUNCTIONAL STATUS; HIGH RISK POPULATION; PHYSICAL DISEASE; PREOPERATIVE PERIOD; RETROSPECTIVE STUDY; SURGICAL RISK; SURVIVAL TIME;

EID: 84936759628     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV10I6A128     Document Type: Article

References (32)

1. Yiu SF, Enriquez-Sarano M, Tribouilloy C, Seward JB, Tajik AJ. Determinants of the degree of functional mitral regurgitation in patients with systolic left ventricular dysfunction: a quantitative clinical study. Circulation. 2000;102:1400-6.
2. Acker MA, Bolling S, Shemin R, Kirklin J, Oh JK, Mann DL, Jessup M, Sabbah HN, Starling RC, Kubo SH; Acorn Trial Principal Investigators and Study Coordinators. Mitral valve surgery in heart failure: insights from the Acorn Clinical Trial. J Thorac Cardiovasc Surg. 2006;132:568-77.
3. Bax JJ, Braun J, Somer ST, Klautz R, Holman ER, Versteegh MI, Boersma E, Schalij MJ, van der Wall EE, Dion RA. Restrictive annuloplasty and coronary revascularization in ischemic mitral regurgitation results in reverse left ventricular remodeling. Circulation. 2004;110:II103-8.
4. De Bonis M, Lapenna E, Verzini A, La Canna G, Grimaldi A, Torracca L, Maisano F, Alfieri O. Recurrence of mitral regurgitation parallels the absence of left ventricular reverse remodeling after mitral repair in advanced dilated cardiomyopathy. Ann Thorac Surg. 2008;85:932-9.
5. Wu AH, Aaronson KD, Bolling SF, Pagani FD, Welch K, Koelling TM. Impact of mitral valve annuloplasty on mortality risk in patients with mitral regurgitation and left ventricular systolic dysfunction. J Am Coll Cardiol. 2005;45:381-7.
6. Mirabel M, Iung B, Baron G, Messika-Zeitoun D, Détaint D, Vanoverschelde JL, Butchart EG, Ravaud P, Vahanian A. What are the characteristics of patients with severe, symptomatic, mitral regurgitation who are denied surgery? Eur Heart J. 2007;28:1358-65.
7. Alfieri O, Maisano F, De Bonis M, Stefano PL, Torracca L, Oppizzi M, La Canna G. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg. 2001;122:674-81.
8. Feldman T, Kar S, Rinaldi M, Fail P, Hermiller J, Smalling R, Whitlow PL, Gray W, Low R, Herrmann HC, Lim S, Foster E, Glower D; EVEREST Investigators. Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. J Am Coll Cardiol. 2009;54:686-94.
9. Feldman T, Foster E, Glower DD, Kar S, Rinaldi MJ, Fail PS, Smalling RW, Siegel R, Rose GA, Engeron E, Loghin C, Trento A, Skipper ER, Fudge T, Letsou GV, Massaro JM, Mauri L; EVEREST II Investigators. Percutaneous repair or surgery for mitral regurgitation. N Engl J Med. 2011;364:1395-406.
10. Rudolph V, Lubos E, Schlüter M, Lubs D, Goldmann B, Knap M, de Vries T, Treede H, Schirmer J, Conradi L, Wegscheider K, Reichenspurner H, Blankenberg S, Baldus S. Aetiology of mitral regurgitation differentially affects 2-year adverse outcomes after MitraClip therapy in high-risk patients. Eur J Heart Fail. 2013;15:796-807.
11. Pleger ST, Mereles D, Schulz-Schönhagen M, Krumsdorf U, Chorianopoulos E, Rottbauer W, Katus HA, Bekeredjian R. Acute safety and 30-day outcome after percutaneous edge-to-edge repair of mitral regurgitation in very high-risk patients. Am J Cardiol. 2011;108:1478-82.
12. Franzen O, van der Heyden J, Baldus S, Schlüter M, Schillinger W, Butter C, Hoffmann R, Corti R, Pedrazzini G, Swaans MJ, Neuss M, Rudolph V, Sürder D, Grünenfelder J, Eulenburg C, Reichenspurner H, Meinertz T, Auricchio A. MitraClip® therapy in patients with end-stage systolic heart failure. Eur J Heart Fail. 2011;13:569-76.
13. Maisano F, Franzen O, Baldus S, Schäfer U, Hausleiter J, Butter C, Ussia GP, Sievert H, Richardt G, Widder JD, Moccetti T, Schillinger W. Percutaneous mitral valve interventions in the real world: early and one year results from the ACCESS-EU, a prospective, multicenter, non-randomized post-approval study of the MitraClip® therapy in Europe. J Am Coll Cardiol. 2013;62: 1052-61.
14. Schillinger W, Hünlich M, Baldus S, Ouarrak T, Boekstegers P, Hink U, Butter C, Bekeredjian R, Plicht B, Sievert H, Schofer J, Senges J, Meinertz T, Hasenfuß G. Acute outcomes after MitraClip therapy in highly aged patients: results from the German TRAnscatheter Mitral valve Interventions (TRAMI) Registry. EuroIntervention. 2013;9:84-90.
15. Maisano F, Denti P, Michev I, La Canna G, Arendar I. Colombo A, Alfieri O. Percutaneous mitral valve repair with the edge-to-edge technique. MMCTS. Published online January 1, 2010.
16. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Barón-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Iung B, Lancellotti P, Pierard L, Price S, Schäfers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M. Guidelines on the management of valvular heart disease (version 2012): The Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2012;33:2451-96.
17. Stone G, Mack M. Clinical Outcomes Assessment of the MitraClip Therapy Percutaneous Therapy for High Surgical Risk Patients (COAPT). http://clinicaltrials.gov/ct2/show/NCT01626079
18. Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A; Acute Kidney Injury Network. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11:R31.
19. Trichon BH, Felker GM, Shaw LK, Cabell CH, O'Connor CM. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol. 2003;91:538-43.
20. Grigioni F, Enriquez-Sarano M, Zehr KJ, Bailey KR, Tajik AJ. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation. 2001;103:1759-64.
21. Bolling SF, Deeb GM, Brunsting LA, Bach DS. Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy. J Thorac Cardiovasc Surg. 1995;109:676-82.
22. Bach DS, Bolling SF. Early improvement in congestive heart failure after correction of secondary mitral regurgitation in end-stage cardiomyopathy. Am Heart J. 1995;129:1165-70.
23. Braun J, Bax JJ, Versteegh MI, Voigt PG, Holman ER, Klautz RJ, Boersma E, Dion RA. Preoperative left ventricular dimensions predict reverse remodeling following restrictive mitral annuloplasty in ischemic mitral regurgitation. Eur J Cardiothorac Surg. 2005;27:847-53.
24. Crabtree TD, Bailey MS, Moon MR, Munfakh N, Pasque MK, Lawton JS, Moazami N, Aubuchon KA, Al-Dadah AS, Damiano RJ Jr. Recurrent mitral regurgitation and risk factors for early and late mortality after mitral valve repair for functional ischemic mitral regurgitation. Ann Thorac Surg. 2008;85:1537-42.
25. De Bonis M, Taramasso M, Grimaldi A, Maisano F, Calabrese MC, Verzini A, Ferrara D, Alfieri O. The GeoForm annuloplasty ring for the surgical treatment of functional mitral regurgitation in advanced dilated cardiomyopathy. Eur J Cardiothorac Surg. 2011;40:488-95.
26. De Bonis M, Lapenna E, La Canna G, Ficarra E, Pagliaro M, Torracca L, Maisano F, Alfieri O. Mitral valve repair for functional mitral regurgitation in end-stage dilated cardiomyopathy: role of the "edge-to-edge" technique. Circulation. 2005;112:I402-8.
27. Scandura S, Ussia GP, Capranzano P, Caggegi A, Sarkar K, Cammalleri V, Mangiafico S, Chiarandà M, Immè S, Di Pasqua F, Pistritto AM, Millan G, Tamburino C. Left cardiac chambers reverse remodeling after percutaneous mitral valve repair with the MitraClip system. J Am Soc Echocardiogr. 2012;25: 1099-105.
28. Paranskaya L, D'Ancona G, Bozdag-Turan I, Akin I, Kische S, Turan GR, Rehders T, Ortak J, Nienaber CA, Ince H. Residual mitral valve regurgitation after percutaneous mitral valve repair with the MitraClip® system is a risk factor for adverse one-year outcome. Catheter Cardiovasc Interv. 2013;81:609-17.
29. Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, Pfisterer M, Perruchoud AP. Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea. N Engl J Med. 2004;350:647-54.
30. Logeart D, Thabut G, Jourdain P, Chavelas C, Beyne P, Beauvais F, Bouvier E, Solal AC. Predischarge B-type natriuretic peptide assay for identifying patients at high risk of re-admission after decompensated heart failure. J Am Coll Cardiol. 2004;43:635-41.
31. Hwang IC, Kim YJ, Kim KH, Lee SP, Kim HK, Sohn DW, Oh BH, Park YB. Prognostic value of B-type natriuretic peptide in patients with chronic mitral regurgitation undergoing surgery: mid-term follow-up results. Eur J Cardiothorac Surg. 2013;43:e1-6.
32. Neuss M, Schau T, Schoepp M, Seifert M, Hölschermann F, Meyhöfer J, Butter C. Patient selection criteria and midterm clinical outcome for MitraClip therapy in patients with severe mitral regurgitation and severe congestive heart failure. Eur J Heart Fail. 2013;15:786-95.